The FDA Antiviral Advisory Committee Meeting NEW!

By Jules Levin, Executive Director of NATAP

---

Review of Abbott's New Drug Application (NDA) for Ritonavir

Review of Merck's New Drug Application (NDA) for Indinavir

---

This document was written by Jules Levin, Executive Director of NATAP

Go to the HIV Protease Inhibitor Report Menu

Go to the Protease Inhibitor Menu

Go to the Treatment Menu

Go to the HIVpositive.us Main Menu

39